Inventor · disambiguated record
Paul Allan Renhowe
Also filed as: RENHOWE PAUL ALLAN
17 granted patents·18 pending applications·75 citations·filing 2012–2025
93Inventor score
Top patents by PatentIndex Score
35 records- 0194US9586937B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Granted Mar 7, 2017·13 cites·2 claims
- 0293US9481689B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·16 cites·2 claims
- 0391US10858363B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Dec 8, 2020·4 cites·10 claims
- 0491US10183021B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2016·Granted Jan 22, 2019·8 cites·9 claims
- 0591US9139564B22-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2012·Granted Sep 22, 2015·15 cites·6 claims
- 0690US10639308B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2018·Granted May 5, 2020·3 cites·31 claims
- 0789US2025243228A1PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0887US10517874B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Dec 31, 2019·4 cites·17 claims
- 0986US2024360164A1Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1085US10472363B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Nov 12, 2019·3 cites·2 claims
- 1185US2024228520A9Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1280US10047095B2sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·4 cites·26 claims
- 1377US11180493B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Nov 23, 2021·2 cites·10 claims
- 1477US10844064B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2015·Granted Nov 24, 2020·2 cites·9 claims
- 1577US2023106002A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1675US11731977B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·0 cites·18 claims
- 1774US2025243205A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1873US2025326761A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1973US2025059197A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2071US11897887B2sGC stimulatorsTISENTO THERAPEUTICS INC·Filed 2018·Granted Feb 13, 2024·1 cites·24 claims
- 2171US11207323B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·0 cites·4 claims
- 2271US2021087198A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2370US2021221793A1Pyrazole derivatives as sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2467US10927136B2Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Feb 23, 2021·0 cites·16 claims
- 2566US12435080B2sGC stimulatorsTISENTO THERAPEUTICS INC·Filed 2021·Granted Oct 7, 2025·0 cites·6 claims
- 2661US2021214364A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2760US2019284168A1Pyrazole derivaties as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2858US2019031641A1Pyrazole derivatives as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2958US2024208979A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3056US2024207265A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3153US2016311826A1Sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3251US2017291889A1Pyrazole derivatives as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3347US11357777B2Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)CYCLERION THERAPEUTICS INC·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 3442US2015342954A12-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3535US2017298055A1sGC STIMULATORSIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →